Pivot Pharmaceuticals Inc. (OTCMKTS:PVOTF) has announced that they have signed a strategic manufacturing agreement with Growpacker Inc. The agreement is meant for the production of Pivot’s patented and differentiated cream, topical gels and beverages in the California cannabis market.

The launch of bio cannabis products

According to the agreement, Pivot will be able to launch their bio cannabis products in the market at affordable costs to augment the production of their Costa Mesa facility in California.

Growpacker expects to start the manufacture of the patented bio cannabis creams, topical gels, and beverages in California and they will launch the products in the Q2 of 2019. In addition to the licensed Costa Mesa Facility, the Growpacker facility will enhance the production of the cannabis products on large scale. The company employs their novel oil-to-powder technology to render CBD and THC insoluble and they will use it in the production of Pivot’s patented wellness and Health bio cannabis products.

Enhancing production to meet market demand

Stephen Boyd, the CEO of Growpacker stated that they were delighted to collaborate with Pivot Pharma because their facility was ideal for the production of Pivot’s line of topical gels, beverages as well as creams. Mr. Stephen indicated that their patented technology and formulations will be crucial in the production process as they strive to meet the market demands of the cannabis industry.

Speaking about the Growpacker facility, Pivot Pharma CEO, Patrick Frankman, indicated that Mr. Boyd had done exceptional work in the development of a state of the art facility that can appeal to high-end customers and development partners. He added that he believed that the facility will provide them with the best environment to enhance their production.

The Pivot CEO said that the Cost Mesa facility will continue with the production of bulk powder, Capsules, tablets and stick packs.

Pivot management has built a great company that is leading the acquisition of intellectual rights in the cannabis industry and the formulation of bio-available pharmaceuticals across Canada. The company has positioned itself as a leader in the cannabis industry across the world and they are planning to launch their line products in different regions to enable them to have a competitive edge over rivals.